SkinBioTherapeutics plc (AIM:SBTX)

SkinBioTherapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 4, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	39	43	18	22	32	100
Market Cap Growth	7.93%	144.31%	-17.78%	-31.83%	-68.11%	353.88%
Enterprise Value	35	43	15	21	29	94
Last Close Price	0.15	0.17	0.09	0.13	0.20	0.64
PS Ratio	8.44	9.37	14.72	163.89	424.66	-
PB Ratio	4.16	4.62	5.99	10.85	12.83	19.09
P/TBV Ratio	7.63	8.48	-	16.72	17.16	21.24
EV/Sales Ratio	7.62	9.33	12.45	158.92	384.18	-
Debt / Equity Ratio	0.11	0.11	0.28	0.05	0.05	0.03
Asset Turnover	0.54	0.54	0.31	0.05	0.02	-
Inventory Turnover	2.80	2.80	2.08	0.60	-	-
Quick Ratio	4.29	4.29	0.63	3.05	4.19	11.91
Current Ratio	4.84	4.84	0.93	3.25	4.58	12.50
Return on Equity (ROE)	-11.24%	-11.24%	-115.85%	-126.85%	-72.62%	-37.31%
Return on Assets (ROA)	-8.10%	-8.10%	-46.50%	-66.02%	-42.26%	-22.00%
Return on Capital (ROIC)	-9.89%	-9.89%	-61.71%	-79.79%	-46.84%	-23.93%
Return on Capital Employed (ROCE)	-10.50%	-10.50%	-85.20%	-145.30%	-115.80%	-28.10%
Earnings Yield	-1.78%	-1.60%	-16.16%	-13.10%	-8.80%	-1.44%
FCF Yield	-3.17%	-2.85%	-15.40%	-12.64%	-8.42%	-1.56%
Buyback Yield / Dilution	-20.57%	-20.57%	-13.10%	-5.06%	-6.87%	-14.53%

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.